Table 3 Apo(a) phenotypes distribution in the study groups.
| Â | n | Subjects with at least one apo(a) isoform of low molecular weight | Subjects with only apo(a) isoforms of high molecular weight |
|---|---|---|---|
Overweight subjects with CHD | 155 | 86 (55.5%)* | 69 (44.5%) |
Overweight subjects without CHD | 120 | 49 (40.8%) | 71 (59.2%) |
Normal weight subjects with CHD | 337 | 192 (57%)** | 145 (43%) |
Controls | 103 | 41 (39.8%) | 62 (60.2%) |